Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Receivables (2020 - 2025)

Bio Essence (BIOE) has 6 years of Receivables data on record, last reported at $4969.0 in Q3 2025.

  • For Q3 2025, Receivables fell 98.11% year-over-year to $4969.0; the TTM value through Sep 2025 reached $4969.0, down 98.11%, while the annual FY2024 figure was $5124.0, 99.5% down from the prior year.
  • Receivables reached $4969.0 in Q3 2025 per BIOE's latest filing, roughly flat from $4969.0 in the prior quarter.
  • Across five years, Receivables topped out at $1.0 million in Q4 2023 and bottomed at $4969.0 in Q2 2025.
  • Average Receivables over 5 years is $143864.4, with a median of $24268.0 recorded in 2021.
  • Peak YoY movement for Receivables: surged 3732.51% in 2022, then crashed 99.5% in 2024.
  • A 5-year view of Receivables shows it stood at $16820.0 in 2021, then soared by 3732.51% to $644628.0 in 2022, then skyrocketed by 58.37% to $1.0 million in 2023, then plummeted by 99.5% to $5124.0 in 2024, then dropped by 3.02% to $4969.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $4969.0 in Q3 2025, $4969.0 in Q2 2025, and $8191.0 in Q1 2025.